Thoma Jeanne sold $72K of ANIP
Thoma Jeanne sold 1,000 shares of ANI PHARMACEUTICALS INC (ANIP) at $71.53 on 2026-09-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and pre‑arranged, implying limited new information for traders.
Market read
Primary relevance is to traders monitoring insider activity; broader market impact is negligible.
What to watch
Potential future insider transactions or cumulative insider activity could be more telling than this single sale.
Background
Form 4 filings disclose insider transactions; directors often use 10b5-1 plans to pre‑schedule sales.
Ticker impact
Director Thoma Jeanne sold 1,000 shares for $71,530 via a 10b5-1 plan, reducing her holdings to 26,762 shares.
little to no movement
Sale size is modest relative to float and disclosed under a pre-arranged plan, indicating no urgent information.
Market effects
None; the transaction is company‑specific and does not affect the broader pharmaceutical sector.
None; the filing is US‑based and limited to ANI Pharmaceuticals.
Minimal; only relevant to investors tracking insider activity.
Counterpoint
The sale could signal undisclosed concerns, but the 10b5-1 plan suggests routine liquidity management.
Key entities
- CompanyANI Pharmaceuticals Inc
US‑listed pharmaceutical company (ticker ANIP).
- DirectorThoma Jeanne
Director of ANI Pharmaceuticals who sold shares.
